生物技術 業務的一部分 生命科學.
生物技術之智財保護的前導
50多年的執業中,Finnegan飛翰與生技領域的先驅廠商合作,制訂與執行成功的智財策略,包括就突破性進步取得專利,透過訴訟實施專利權,以及針對他人侵權與所有權的指控作辯護。我們代表禮來公司,在世界首推的生物科技產品(人工胰島素) 的訴訟案獲得勝訴,並且就一系列的生物技術提供諮詢或訴訟的服務,像是DNA自動定序,桃莉羊的複製,檢測胚胎染色體數異常的非侵入性方法,以及抗體平台設計。
了解法律,科學,和技術
強健的智財保護對於生技產業的推動是不可或缺的,並且依舊為其持續發展的關鍵。身為由科學家和生物技術工程師組成的智財權律師事務所,Finnegan期許能與科技的快速發展,和這個跨領域產業中不斷變化的法律議題齊頭並進。
隨著生技領域客戶以我們尚未想到的方式取得振奮人心的突破,我們透過以下方式提供協助:
我們在既有和新興領域與客戶合作,包括:
保護創新之全面的法律,技術,和策略經驗
我們的生命科學業務由250多位律師和專業人士組成,致力於滿足客戶對於智財權服務的需求。多數擁有與生物學,化學,生物化學,醫學,藥理學,或生醫工程等相關學科的高階學位。大多具有紮實的研究和/或產業經驗,許多人在產業或大學任職,或在美國專利商標局擔任審查委員後加入Finnegan飛翰。
Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.
Representing Sarepta in defensive patent litigation involving Elevidys®, a one-time gene therapy for the treatment of a neuromuscular disease known as Duchenne muscular dystrophy (DMD) and in parallel offensive inter partes reviews (IPRs).
1:24-cv-00882, D. Del., Judge Andrews
2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre
Representing plaintiff Pioneer in a district court patent infringement litigation involving methods for producing doubled haploid maize plants.
1:22-cv-01280, D. Del.
N22C-07-168, Delaware Superior Court, Complex Commercial Litigation Division
Representing plaintiff Corteva Agriscience in a district court patent infringement litigation involving transgenic plants and plant cells that produce enzymes conferring herbicide resistance.
1:22-cv-01046, D. Del., Judge Williams
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Press Release
London-Based Life Sciences Litigator Jin Ooi Bolsters Finnegan’s Global IP Litigation Capabilities
June 8, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.